KRAS and pachyonychia congenita: Our data demonstrates that CXCR2 signaling mediates KRAS-induced PC growth and suggests that targeting CXCR2 signaling might be a feasible approach to inhibit KRAS(G12D)-induced PDAC tumor cell growth.